Equivalence of conventional anti-picryl T suppressor factor in the contact sensitivity system and monoclonal anti-NP TsF3: their final non-specific effect via the T acceptor cellT suppressor cells and suppressor factor which act at the efferent stage of the contact sensitivity skin reaction: their production by mice injected with water-soluble, chemically reactive derivatives of oxazolone and picryl chlorideDetection of isolated tumour cells in the blood and bone marrow of patients with gastric cancer by combined sorting, isolation and determination of MAGE-1, -2 mRNA expression.Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.Interactions of human monocytes with TMVs (tumour-derived microvesicles).Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndromeIntrauterine exposure to lead may enhance sensitization to common inhalant allergens in early childhood: a prospective prebirth cohort study.Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience.Contact sensitivity in the mouse. IV. The role of lymphocytes and macrophages in passive transfer and the mechanism of their interaction.Intermediary role of macrophages in the passage of suppressor signals between T-cell subsetsThe effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients.Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicityProperties of monocytes generated from haematopoietic CD34(+) stem cells from bone marrow of colon cancer patients.I-A region genetic restriction in the production and action of an antigen-specific T-helper factor which bears I-A region determinant(s).T suppressor factor activity is due to two separate molecules. The Lyt-1(-)2+I-J+ cells of mice primed with antigen make an antigen binding molecule which is only active when complemented by cofactor made by Lyt-1+2(-)I-J+ cells.Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-speciControl of suppressor cell activity: autoanti-idiotype B cells produced by painting with picryl chloride inhibit the T-suppressor cell which blocks the efferent stage of contact sensitivity.Inhibition of contact sensitivity by macrophages.Control of the immune reaction: T cells in immunized mice which depress the in vivo DNA synthesis response in the lymph nodes to skin painting with the contact sensitizing agent picryl chloride.Analysis of the induction phase of contact sensitivity by footpad transfer of regional lymph node cells. Macrophages and radioresistant T-lymphocytes induce immunity.Suppressor T cell product, which depresses the passive transfer of contact sensitivity, shares epitope(s) with the major histocompatibility complex.The effect of cyclophosphamide and irradiation on cells which suppress contact sensitivity in the mouse.Occurrence of suppressor cells in lymph nodes and spleen at later times after immunization with contact-sensitizing agent picryl chloride.Hyaluronan carried by tumor-derived microvesicles induces IL-10 production in classical (CD14(++)CD16(-)) monocytes via PI3K/Akt/mTOR-dependent signalling pathway.Chemokine receptors and chemokine production by CD34+ stem cell-derived monocytes in response to cancer cells.An overview of T-suppressor cell circuits.Tumour-derived microvesicles (TMV) mimic the effect of tumour cells on monocyte subpopulations.Macrophage metabolism during phagocytosis and digestion of normal and IgG antibody-coated sheep erythrocytes.Blood monocytes stimulate migration of human pancreatic carcinoma cells in vitro: the role of tumour necrosis factor - alpha.Adult thymectomy prevention of the appearance of suppressor T cells which depress contact sensitivity to picryl chloride and reversal of adult thymectomy effect by thymus extract.Risk of wheezing associated with house-dust mite allergens and indoor air quality among three-year-old children. Kraków inner city study.Human monocytes both enhance and inhibit the growth of human pancreatic cancer in SCID mice.Tumour-derived microvesicles modulate biological activity of human monocytes.Suppressor cells and the handling of antigen.Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes.Modulation of monocyte-tumour cell interactions by Mycobacterium vaccae.Depressed tumor necrosis factor alpha and interleukin-12p40 production by peripheral blood mononuclear cells of gastric cancer patients: association with IL-1R-associated kinase-1 protein expression and disease stage.Involvement of pattern recognition receptors in the induction of cytokines and reactive oxygen intermediates production by human monocytes/macrophages stimulated with tumour cells.Prevention and reversal of tumor cell-induced monocyte deactivation by cytokines, purified protein derivative (PPD), and anti-IL-10 antibody.Antitumor response of CD14+/CD16+ monocyte subpopulation.
P50
Q28366365-79C3CD69-979D-43A8-B478-CA1BCDA4B08FQ28366700-1BA3219A-7AD2-4240-A953-DF6928B2BD40Q33324993-438EAAD7-CFD8-4219-AD49-990702A876E2Q33328785-D0FF2151-4482-4B5D-889B-F4A273DDF246Q33355180-D416689C-AEC7-425C-9CA8-7A06BD12947FQ33587849-E6358895-12B6-4994-A596-E73A14A15B26Q34516668-DFD29F1B-E5D5-4FA4-A6BF-764EBDF4C787Q35093986-A71DA1E8-C766-4ED5-8F02-F9E7BA89C260Q36270079-88F33EE1-EFBD-4087-B204-7D08F8622311Q36341805-571AB20C-8905-413E-A46D-63BECDC11A34Q36611069-1952B740-DB9A-47A3-B8C7-7B72693A676AQ36618948-9D89F4F4-216E-4CF2-A36C-FC8CEEB1F75DQ36759291-D5A1F0CD-9714-4AB7-B7AC-BC77D3710502Q38520480-5740C01F-467A-4FAC-8EA6-5807A04BF0C0Q38521557-775154BD-370F-47CD-A309-491744EF88F2Q38522672-AEA39C77-5A03-4E09-88A2-4BA403821FACQ38523198-FCCCFDEA-C525-4E70-BDF1-C293CDC5E806Q38524336-0A0AEEA9-6A13-4EDE-B29B-553D0F0C56EFQ38525997-BA09E160-CFE2-4C07-96B1-E22A0300F875Q38526135-C3D27CF0-48F9-4D96-943B-C1A2822CE6BDQ38526153-64F51ACB-87B7-4F63-AB9B-3B0EA6D2D6FDQ38526478-B6BA4224-1434-492C-8163-14E9D5B88EB6Q38526551-1D676A5B-8AE6-4B2A-9262-E21AB8B7E429Q38526551-81E37549-2B72-43CA-8FEA-3408630563C1Q38849409-15809ADF-4B9B-4F32-B63E-4ADDAFC6FE35Q39244037-563CBF3C-8FA7-4B96-8BC9-C60267B28B2DQ39478451-821E6977-265B-4F2C-97E7-578B8685E3FBQ39644622-3BA9BD7E-6E6A-4B7A-9469-46B69F36EEA0Q39734034-8BFBC9E8-F903-4AF9-8925-A1F5004D64ADQ39794959-2E0C4A09-006E-4EFB-A2FC-6583B4480021Q39802098-A9D822B3-23FB-4315-8DF0-DEF588D8CEA5Q39805184-8BFDDF9A-D722-4F87-B44E-CA474B927AB5Q39995879-95C05A8C-80E6-46C2-9945-1F7A17959663Q40083396-F2AD57C4-ED1F-4C5F-B549-336B479B0B2CQ40217210-B27F7D02-509F-444E-9432-78200E70F537Q40352193-A392F76A-A8D3-4EAA-9249-6641C6AC30F9Q40461048-99AD5167-4E9D-43D7-A7CE-798B6A526B0AQ40496319-EDEBFAB9-9C62-44D6-8154-94D8178B42B2Q40522286-BC8D0CD6-2478-4FF3-A444-D4EE5ACE355DQ40522814-770D475D-E113-4C67-883C-AFE13670BFC3
P50
description
Polish immunologist
@en
Pools immunoloog
@nl
polski immunolog
@pl
name
Marek Zembala
@ast
Marek Zembala
@en
Marek Zembala
@es
Marek Zembala
@ga
Marek Zembala
@nl
Marek Zembala
@pl
Marek Zembala
@sl
type
label
Marek Zembala
@ast
Marek Zembala
@en
Marek Zembala
@es
Marek Zembala
@ga
Marek Zembala
@nl
Marek Zembala
@pl
Marek Zembala
@sl
prefLabel
Marek Zembala
@ast
Marek Zembala
@en
Marek Zembala
@es
Marek Zembala
@ga
Marek Zembala
@nl
Marek Zembala
@pl
Marek Zembala
@sl
P214
P106
P1559
Marek Zembala
@pl
P21
P214
P27
P31
P3124
P569
1940-01-01T00:00:00Z
P734
P735
P7859
viaf-161241714